510(k) Report

510(k) · Cleared

Cleared

Sonoline Elegra with Siescape Feature

K961833510(k) TraditionalCleared Oct 29, 1996169-day reviewClass II21 CFR 892.1560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Medical Solutions USA, Inc. · IYO System, Imaging, Pulsed Echo, Ultrasonic

Cleared on Oct 29, 1996 as substantially equivalent to K945072 (Siemens Medical Solutions USA, Inc., 1995) after a 169-day review. Its family tree reaches back 1 generation to 1995. 1 later device descends from it.

Decided
Oct 29, 1996
Review
169 days
Class
Class II
Product code
IYO
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K945072 (1995). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 1998: 1 descendant clearedK945072 · Siemens Q4000 · Siemens Medical Solutions USA, Inc. · 19951995200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant K945072 · Siemens Q4000 · Siemens Medical Solutions USA, Inc. · 19950
  1. Root · 1 generation backK945072 Siemens Q4000Siemens Medical Solutions USA, Inc. · 1995
  2. This deviceK961833 Sonoline Elegra with Siescape FeatureSiemens Medical Solutions USA, Inc. · 1996
  3. Descendant · cites it directly · 0 of its ownK981626 Sonoline Elegra Diagnostic Ultrasound SystemSiemens Medical Solutions USA, Inc. · 1998

Most influential descendants

Showing 1 of 1 · See all
  • K981626Sonoline Elegra Diagnostic Ultrasound SystemSiemens Medical Solutions USA, Inc. · 1998 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K945072Siemens Q4000Siemens Medical Solutions USA, Inc.1995—
0 (this device)K961833Sonoline Elegra with Siescape FeatureSiemens Medical Solutions USA, Inc.1996—
+1K981626Sonoline Elegra Diagnostic Ultrasound SystemSiemens Medical Solutions USA, Inc.1998—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199810
FIG. 1 — Lineage of K961833, 1995–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IYO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IYO device

  1. #1 K243937 Accuro 3Sscore 20.5 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K945072Siemens Q4000
Summary page 1
…Uitrasonic Pulsed Doppler Imaging System (Product Code 90 IYN, 21 CFR 892.1550) 3. Predicate Device: Siemens SONOLINE Elegra Platform 256 Diagnostic Ultrasound System (K945072), 11/21/95 4. Device Description: The SONOLINE Elegra is a general purpose, mobile, software-controlied, diagnostic ultrasound s…
Siemens Medical Solutions USA, Inc.1995—

Also cleared against K945072: 5 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K981626Sonoline Elegra Diagnostic Ultrasound SystemSiemens Medical Solutions USA, Inc.19980

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K981626 (Siemens Medical Solutions USA, Inc., 1998) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K945072.

How does its category compare?

All IYO devices

IYO System, Imaging, Pulsed Echo, Ultrasonic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · IYO

7in 2025

2007: 202008: 142009: 132010: 152011: 112012: 152013: 172014: 142015: 192016: 102017: 192018: 142019: 132020: 112021: 152022: 52023: 112024: 102025: 72026 (partial year): 10
2007high 20 (2007) · low 5 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IYO

171in 2025

2007: 17 days median2008: 36 days median2009: 79 days median2010: 113 days median2011: 69 days median2012: 68 days median2013: 50 days median2014: 63 days median2015: 46 days median2016: 36 days median2017: 72 days median2018: 56 days median2019: 59 days median2020: 57 days median2021: 64 days median2022: 190 days median2023: 177 days median2024: 220 days median2025: 171 days median2026 (partial year): 139 days median
2007high 220 (2024) · low 17 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IYO

1in 2022

2007: 42008: 52009: 92010: 82012: 22013: 32014: 22015: 12018: 12019: 12021: 112022: 12026 (partial year): 1
2007high 11 (2021) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IYO

485in 2025

2007: 392008: 202009: 272010: 202011: 582012: 782013: 4362014: 3042015: 2682016: 2542017: 2382018: 3682019: 5372020: 4982021: 6172022: 5112023: 5272024: 6402025: 485
2007high 640 (2024) · low 20 (2008)2025

MAUDE reports naming product code IYO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072017439
20081436520
20091379927
201015113820
20111169058
20121568278
201317503436
201414632304
201519461268
201610360254
201719720238
201814561368
201913591537
202011570498
2021156411617
202251901511
2023111770527
2024102200640
202571710485
2026101391—

What is it indicated for?

The SONOLINE Elegra ultrasound imaging system is intended for the following applications: General Radiology, Abdominal, intraoperative, Small Parts, Transcranial, OB/GYN, Pelvic, Neonatal/Adult Cephalic, Urology, Vascular, and Peripheral Vascular applications. The addition of SieScape with Measurements will not change or add to the intended uses above, which are identical to those included in the original submission for the Elegra. The system also…

Read the full statement (105 words)

The SONOLINE Elegra ultrasound imaging system is intended for the following applications: General Radiology, Abdominal, intraoperative, Small Parts, Transcranial, OB/GYN, Pelvic, Neonatal/Adult Cephalic, Urology, Vascular, and Peripheral Vascular applications. The addition of SieScape with Measurements will not change or add to the intended uses above, which are identical to those included in the original submission for the Elegra.

The system also provides for the measurement of anatomical structures and for analysis packages that provide information that is used for clinical diagnosis purposes. The addition of SieScape with Measurements will allow for measurements across a wider field of view than with standard B-mode imaging ultrasound systems.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K961833: Sonoline Elegra with Siescape Feature.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K961833

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026